Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite (Q34446998)

2 August 2017

Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite (English)

1 reference

2 August 2017

0 references

1 reference

M Hermanussen

1

1 reference

2 August 2017

A P García

2

1 reference

2 August 2017

M Sunder

3

1 reference

2 August 2017

M Voigt

4

1 reference

2 August 2017

V Salazar

5

1 reference

2 August 2017

J A F Tresguerres

6

1 reference

2 August 2017

1 January 2006

1 reference

European Journal of Clinical Nutrition

2 August 2017

1 reference

2 August 2017

60

1 reference

2 August 2017

25-31

1 reference

2 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602263

2 August 2017

0 references

cites work

Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Monosodium glutamate induced lesions of the arcurate nucleus. II. Fluorescence histochemistry of catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

The function of the amino terminal domain in NMDA receptor modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Obesity rising to alarming levels around the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Brain lesions in an infant rhesus monkey treated with monsodium glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Television viewing and childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

A leptin missense mutation associated with hypogonadism and morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

The role of exercise in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Nitric oxide synthase-, N-methyl-D-aspartate receptor-, glutamate- and aspartate-immunoreactive neurons in the mouse arcuate nucleus: effects of neonatal treatment with monosodium glutamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

Body weight and the shape of the natural distribution of weight, in very large samples of German, Austrian and Norwegian conscripts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

The safety evaluation of monosodium glutamate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602263

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602263

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference